APA (7th ed.) Citation

Powell, N., Mehandru, S., Silverberg, M., Peyrin-Biroulet, L., Hernandez-Rocha, C., Colombel, J. F., . . . Farahmand, S. (2026). Molecular and cellular signatures accompanying early disease clearance in Ulcerative Colitis patients treated with vedolizumab in the VERDICT trial. Journal of Crohn's & Colitis, 20, i206.

Chicago Style (17th ed.) Citation

Powell, N., et al. "Molecular and Cellular Signatures Accompanying Early Disease Clearance in Ulcerative Colitis Patients Treated with Vedolizumab in the VERDICT Trial." Journal of Crohn's & Colitis 20 (2026): i206.

MLA (9th ed.) Citation

Powell, N., et al. "Molecular and Cellular Signatures Accompanying Early Disease Clearance in Ulcerative Colitis Patients Treated with Vedolizumab in the VERDICT Trial." Journal of Crohn's & Colitis, vol. 20, 2026, p. i206.